Ibrutinib-MPEA
Product Specifications
CAS Number
1710768-30-1
Target
Others, BTK
Related Pathways
Others, Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
Ibrutinib-MPEA is ibrutinib derivative. Ibrutinib is a covalent and irreversible BTK inhibitor that has been used to treat hematological malignancies.
Smiles
NCCN1CCN(C\C=C\C(=O)N2CCC[C@H](C2)n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc23)CC1
Molecular Formula
C32H39N9O2
Molecular Weight
581.71
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
226772-01 50 µL
ZNF801 (Myc-Associated zinc Finger Protein, MAZI, Pur-1, Purine-Binding Transcription Factor, Serum Amyloid A-Activating Factor-1, SAF-1, Transcription Factor Zif87, ZF87, Zinc Finger Protein 801, MAZ, SAF1, Pur1) discontinued
Sign In for Pricing
View Details 226772-02 100 µL
ZNF801 (Myc-Associated zinc Finger Protein, MAZI, Pur-1, Purine-Binding Transcription Factor, Serum Amyloid A-Activating Factor-1, SAF-1, Transcription Factor Zif87, ZF87, Zinc Finger Protein 801, MAZ, SAF1, Pur1) discontinued
Sign In for Pricing
View Details 
